This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robertson, K. A. Articles by Allen, J. R. Search for Related Content PubMed PubMed Citation Articles by Robertson, K. A. Articles by Allen, J. R.

Covalent Interaction of Dehydroretronecine, a Carcinogenic Metabolite of the Pyrrolizidine Alkaloid Monocrotaline, with Cysteine and Glutathione¹

Department of Pathology, University of Wisconsin Medical School, and Regional Primate Research Center, University of Wisconsin, Madison, Wisconsin 53706

The covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione, has been investigated. Dehydroretronecine was allowed to react with cysteine and glutathione in an in vitro system of phosphate buffer solutions. The reaction products were identified structurally by chromatographic, nuclear magnetic resonance, infrared, ultraviolet, and mass-spectral analysis. These data indicate that the reaction products are the sulfhydryl-linked 7-thiocysteine-dehydroretronecine and 7-thioglutathione-dehydroretronecine. Active alkylation of sulfhydryl groups is a possible mechanism by which these alkaloids interact with cellular components.

¹ This investigation was supported in part by USPHS Grants CA-13288, HL-10941, GM-00130, and RR-00167 from NIH. Primate Center Publication 16048.

Received 2/13/76. Accepted 5/20/77.

This article has been cited by other articles:

				G. Lin, Y.-Y. Cui, and E. M. Hawes Characterization of Rat Liver Microsomal Metabolites of Clivorine, an Hepatotoxic Otonecine-Type Pyrrolizidine Alkaloid Drug Metab. Dispos., April 13, 2001; 28(12): 1475 - 1483. [Abstract] [Full Text]

				H. Segall, D. Wilson, J. Dallas, and W. Haddon trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionine Science, August 2, 1985; 229(4712): 472 - 475. [Abstract] [PDF]

				M. W. Lame, A. D. Jones, D. W. Wilson, S. K. Dunston, and H. J. Segall Protein Targets of Monocrotaline Pyrrole in Pulmonary Artery Endothelial Cells J. Biol. Chem., September 8, 2000; 275(37): 29091 - 29099. [Abstract] [Full Text] [PDF]